Patients with advanced Merkel cell carcinoma who developed acquired resistance to immune checkpoint inhibitors (ICIs) experienced improved survival outcomes after receiving salvage therapy, compared with those with primary resistance, according…
Acquired Resistance to ICI Yielded Better Survival Than Primary Resistance in Merkel Cell Carcinoma
